Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...

The FDA approved Pfizer’s Hympavzi, which can be an alternative to intravenous infusions often administered multiple times a ...

Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...

Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current ...

"We have decided not to be involved in the efforts of Starboard Value regarding Pfizer. We are fully supportive of Pfizer ...

As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard ...

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...

On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...

Activist investor Starboard Value is looking to shake up pharma giant Pfizer's sagging stock price.